SYN
Synthetic Biologics Inc
Halal Rating :
Last Price
$1.50
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
261.45%
Company Overview
Exchange
Next Earnings Date
Synthetic Biologics Inc, now known as Theriva Biologics (NYSE American: TOVX), is a clinical-stage company focused on developing therapeutics designed to treat gastrointestinal (GI) diseases in areas of high unmet need. The company is developing novel therapeutics designed to engineer the gut microbiome to treat gastrointestinal diseases.
The company has recently undergone a name change and ticker symbol change from SYN to TOVX. This analysis will focus on the company under its current structure.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Synthetic Biologics Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.